From the analyst's couch: TLR-targeted therapeutics

Nature Reviews Drug Discovery

Volumn 4, Issue 11, 2005, Pages 879-880

  Hoffman, Eric S ^a   Smith, Richard E T ^a   Renaud Jr , Ronald C ^a  

^a JP Morgan   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPLIVAX; ANA 975; ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; AVE 0675; AVE 7279; CANCER VACCINE; CPG 10101; CPG 7909; CRX 527; CRX 675; E 5564; GASTROINTESTINAL AGENT; HEPATITIS B VACCINE; HYB 2055; HYB 2903; IMIQUIMOD; IMOXINE; INTERFERON; INTERLEUKIN 2; ISATORIBINE; PF 3512676; PLACEBO; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VAXIMMUNE;

ACTINIC KERATOSIS; ALLERGIC RHINITIS; ARTICLE; ASTHMA; AUTOIMMUNITY; BACTERIAL INFECTION; BASAL CELL CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONDYLOMA; CROHN DISEASE; DRUG MARKETING; HEPATITIS B; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LUNG NON SMALL CELL CANCER; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RECEPTOR INTRINSIC ACTIVITY; SIDE EFFECT;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; HUMANS; IMMUNITY, NATURAL; MARKETING; TOLL-LIKE RECEPTORS;

EID: 27844468138     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd1880     Document Type: Article

References (3)

1. Goldstein, D. R. Toll-like receptors and other links between innate and acquired alloimmunity. Curr. Opin. Immunol. 16, 538-544 (2004)
2. Pasare, C. & Medzhitov, R. Toll-like receptors: Linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560, 11-18 (2005)
3. Cook, D. N. et. al. Toll-like receptors in the pathogenesis of human disease. Nature Immunol. 5, 975-979 (2004)